Technical Analysis for ANGN - Angion Biomedica Corp.

Grade Last Price % Change Price Change
F 10.75 -2.63% -0.29
ANGN closed down 2.63 percent on Friday, July 23, 2021, on 43 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical ANGN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.63%
Inside Day Range Contraction -2.63%
Wide Bands Range Expansion -2.63%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.41%
MACD Bullish Signal Line Cross Bullish -7.41%
Earnings Movers Other -7.41%
Wide Bands Range Expansion -7.41%
Oversold Stochastic Weakness -7.41%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.36%
Older End-of-Day Signals for ANGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3777, a hepatocyte growth factor mimetic for acute kidney injury, acute lung injury, acute respiratory distress syndrome, central nervous system injuries, and heart injuries. It also develops products, such as ANG-3070 tyrosine kinase inhibitor and rho kinase 2 inhibitor for fibrotic diseases; and CYP11B2, an aldosterone synthase inhibitor for aldosterone-related fibrotic diseases. The company was founded in 1998 and is headquartered in Uniondale, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Tyrosine Kinase Protein Kinase Inhibitor Fibrotic Diseases Acute Kidney Injury Acute Respiratory Distress Syndrome

Is ANGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.3
52 Week Low 10.5
Average Volume 67,490
200-Day Moving Average 0.00
50-Day Moving Average 13.26
20-Day Moving Average 11.82
10-Day Moving Average 11.01
Average True Range 0.78
ADX 25.69
+DI 16.21
-DI 25.48
Chandelier Exit (Long, 3 ATRs) 13.21
Chandelier Exit (Short, 3 ATRs) 12.85
Upper Bollinger Bands 14.50
Lower Bollinger Band 9.14
Percent B (%b) 0.3
BandWidth 45.31
MACD Line -0.70
MACD Signal Line -0.74
MACD Histogram 0.0362
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.01
Resistance 3 (R3) 12.07 11.70 11.80
Resistance 2 (R2) 11.70 11.38 11.68 11.73
Resistance 1 (R1) 11.23 11.18 11.05 11.17 11.66
Pivot Point 10.86 10.86 10.77 10.84 10.86
Support 1 (S1) 10.39 10.54 10.21 10.33 9.84
Support 2 (S2) 10.02 10.34 10.00 9.77
Support 3 (S3) 9.55 10.02 9.70
Support 4 (S4) 9.49